Lineus Medical

Lineus Medical has been granted five additional international patents for its flagship product, SafeBreak® Vascular, in Korea, Brazil, Australia, India, and China.

Lineus Medical is pleased to announce the appointment of Matt Stuckert to its Board of Directors. Stuckert was previously a member of the Lineus Technical Advisory Board.

Lineus Medical announces the completion of a $4.579 million Series C funding round. The Series C round allowed Lineus Medical to expand its sales and clinical education team, secure international regulatory clearances, and obtain additional U.S.

Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States.

Vance Clement, CEO of Lineus Medical, has been selected to join the Association of Vascular Access (AVA) Board of Directors as a Director at Large for a two-year term.

Lineus Medical has been awarded the 2023-2024 University of Arkansas College of Engineering Small Employer of the Year.

Lineus Medical announces that it has added a new executive team member with the hiring of Larry Hayes from Richmond, VA. Larry joins Lineus Medical as Vice President of Sales and leads all sales related efforts for the company.

Lineus Medical is proud to announce the signing of a distribution agreement with the largest independent distributor of vascular access products in Canada, Canadian Hospital Specialties (CHS).

Lineus Medical® is proud to announce the U.S. Food and Drug Administration (FDA) has cleared its flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, midlines, peripherally inserted central...

Health Canada has issued a licence on Lineus Medical's flag ship product, SafeBreak® Vascular, for use on all vascular access lines including peripheral IV catheters, peripherally inserted central catheters, central venous catheters, midlines, IV ports,..